THE REAL EXPERIENCE OF REACHING AN EXTREMELY LOW LDL-C LEVEL IN HIGH RISK PATIENTS

被引：0
|
作者：
Korneva, V. A. [1 ]
Kuznetsova, T. [1 ]
机构：
[1] Petrozavodsk State Univ, Fac Therapy, Petrozavodsk, Russia
来源：
ATHEROSCLEROSIS | 2022年 / 355卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
EP276
引用
收藏
页码：E175 / E175
页数：1
相关论文
共 50 条
  • [41] Low LDL-C levels are associated with risk of mortality in a Chinese cohort study
    Jie-Ming Lu
    Meng-Yin Wu
    Zong-Ming Yang
    Yao Zhu
    Die Li
    Zhe-Bin Yu
    Peng Shen
    Meng-Ling Tang
    Ming-Juan Jin
    Hong-Bo Lin
    Li-Ming Shui
    Kun Chen
    Jian-Bing Wang
    Endocrine, 2021, 73 : 563 - 572
  • [42] Low LDL-C levels are associated with risk of mortality in a Chinese cohort study
    Lu, Jie-Ming
    Wu, Meng-Yin
    Yang, Zong-Ming
    Zhu, Yao
    Li, Die
    Yu, Zhe-Bin
    Shen, Peng
    Tang, Meng-Ling
    Jin, Ming-Juan
    Lin, Hong-Bo
    Shui, Li-Ming
    Chen, Kun
    Wang, Jian-Bing
    ENDOCRINE, 2021, 73 (03) : 563 - 572
  • [43] LDL-C TREATMENT GAPS IN STATIN-TREATED PATIENTS AT HIGH AND VERY HIGH CARDIOVASCULAR RISK IN EUROPE
    Gitt, A. K.
    Ambegaonkar, B.
    Brudi, P.
    Lautsch, D.
    ATHEROSCLEROSIS, 2014, 235 (02) : E106 - E106
  • [44] LDL-C lowering with inclisiran - a single centre experience
    Thum, C. H.
    Rosman, A.
    Choong, S. Y.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2023, 393
  • [45] The LDL-C/Apo B predicts coronary atherosclerotic heart disease in non-diabetic patients without high LDL-C
    Jung, Hae Won
    Ra, Moni
    Bae, Han Joon
    Hong, Seung-Pyo
    MEDICINE, 2023, 102 (01) : E32596
  • [46] Effectiveness of rosuvastatin in reducing LDL-C and target LDL-C goal attainment in real-world clinical practice
    Gandhi, Sanjay K.
    Jarbrink, Krister
    Fox, Kathleen M.
    Brandrup-Wognsen, Gunnar
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (12) : 2817 - 2828
  • [47] COST-EFFECTIVENESS OF LDL-C LOWERING WITH EVOLOCUMAB IN PATIENTS WITH HIGH CARDIOVASCULAR RISK IN THE UNITED STATES
    Gandra, S. R.
    Villa, G.
    Fonarow, G.
    Lothgren, M.
    Lindgren, P.
    Somaratne, R.
    van Hout, B.
    VALUE IN HEALTH, 2016, 19 (03) : A3 - A3
  • [48] LDL-C GOALS ATTAINMENT IN PATIENTS AT VERY HIGH CARDIOVASCULAR RISK: A MULTICENTRIC RWE EVALUATION IN COLOMBIA
    Cordoba, B.
    Giraldo, H. Leon
    Quintero, V
    Sabogal, J.
    Ayala, M.
    Buitrago, A. F.
    Herrera, A.
    Zarate, J.
    Cruz, J.
    Velasquez, J.
    Ordonez, P. Rodriguez
    Albaran, C.
    Rodriguez, M. Rojas
    Londono, S.
    Mesa, J. Gomez
    VALUE IN HEALTH, 2024, 27 (12)
  • [49] Cost-Effectiveness of LDL-C Lowering With Evolocumab in Patients With High Cardiovascular Risk in the United States
    Gandra, Shravanthi R.
    Villa, Guillermo
    Fonarow, Gregg C.
    Lothgren, Mickael
    Lindgren, Peter
    Somaratne, Ransi
    van Hout, Ben
    CLINICAL CARDIOLOGY, 2016, 39 (06) : 313 - 320
  • [50] Cardiovascular Outcomes of Early LDL-C Goal Achievement in Patients with Very-High-Risk ASCVD
    Kim, Ah-Ram
    Han, Ji Ye
    Kim, Minkyoung
    Lee, Hojoon
    Baek, Yeon-Hee
    Ahn, Imjin
    Kang, Hee Jun
    Oh, Ji Seon
    Kim, Ju Hyeon
    Kwon, Osung
    Jun, Tae Joon
    Kwon, Sun U.
    Kim, Young-Hak
    CARDIOLOGY AND THERAPY, 2025, 14 (01) : 101 - 115
12345